| Title |
Cost-effectiveness of the Surviving Sepsis Campaign protocol for severe sepsis: a prospective nation-wide study in Spain
|
|---|---|
| Published in |
Intensive Care Medicine, December 2010
|
| DOI | 10.1007/s00134-010-2102-3 |
| Pubmed ID | |
| Authors |
David Suarez, Ricard Ferrer, Antonio Artigas, Izaskun Azkarate, José Garnacho-Montero, Gemma Gomà, Mitchell M. Levy, Juan Carlos Ruiz, For the Edusepsis Study Group |
| Abstract |
Severe sepsis is associated with high mortality and increased costs. The 'Surviving Sepsis Campaign' (SSC) protocol was developed as an international initiative to reduce mortality. However, its cost-effectiveness is unknown. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 50% |
| Science communicators (journalists, bloggers, editors) | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 119 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 2 | 2% |
| Bulgaria | 1 | <1% |
| United Kingdom | 1 | <1% |
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 113 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 19 | 16% |
| Other | 17 | 14% |
| Student > Master | 15 | 13% |
| Student > Postgraduate | 12 | 10% |
| Student > Doctoral Student | 10 | 8% |
| Other | 30 | 25% |
| Unknown | 16 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 66 | 55% |
| Nursing and Health Professions | 7 | 6% |
| Biochemistry, Genetics and Molecular Biology | 6 | 5% |
| Agricultural and Biological Sciences | 5 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 3% |
| Other | 10 | 8% |
| Unknown | 21 | 18% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 October 2017.
All research outputs
#6,259,068
of 22,711,242 outputs
Outputs from Intensive Care Medicine
#2,583
of 4,970 outputs
Outputs of similar age
#45,427
of 180,373 outputs
Outputs of similar age from Intensive Care Medicine
#13
of 25 outputs
Altmetric has tracked 22,711,242 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 4,970 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.6. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 180,373 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.